A single assessment of methotrexate levels at 42 hours permits safe administration and early discharge in children with lymphoblastic lymphoma and leukemia receiving high-dose methotrexate.

Autor: Totadri, Sidharth1 (AUTHOR), Srinivasan, Hema Nalapullu1 (AUTHOR), Joseph, Leenu Lizbeth1 (AUTHOR), Boddu, Deepthi1 (AUTHOR), Mathew, Leni Grace1 (AUTHOR), John, Rikki1 (AUTHOR)
Zdroj: Pediatric Hematology & Oncology. Aug2021, Vol. 38 Issue 5, p434-443. 10p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje